Pretomanid
Pretomanid is a pharmaceutical drug with 15 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
9
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
5
trials recruiting
15
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis
Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
A Pan-TB Regimen Targeting Host and Microbe
Clinical Trials (15)
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis
Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
A Pan-TB Regimen Targeting Host and Microbe
Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis
A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis
Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid
Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial
Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)
Economic Evaluation of New MDR TB Regimens
Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients
Modified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in India
Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis
PRACTECAL-PKPD Sub Study
All 15 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 15